MRI Apparent Diffusion Coefficient (ADC) as a biomarker of tumour response : imaging-pathology correlation in patients with hepatic metastases from colorectal cancer (EORTC 1423)
Source
Cancers - ISSN 2072-6694-15:14 (2023) p. 1-15
Prospective comparison of [¹⁸F]AlF-NOTA-octreotide PET/MRI to [⁶⁸Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
Source
EJNMMI research - ISSN 2191-219X-13:1 (2023) p. 1-13
The clinical value of combined FDG-PET/CT imaging in response evaluation after chemoradiotherapy in patients with potentially operable locally advanced head and neck squamous cell carcinoma
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, Department of Nuclear Medicine, 2023,148 p.
¹⁸F-FDG and ¹⁸F-FLT uptake profiles for breast cancer cell lines treated with targeted PI3K/Akt/mTOR therapies
Source
Cancer biotherapy and radiopharmaceuticals - ISSN 1084-9785-38:1 (2023) p. 51-61
¹⁸F-AlF-NOTA-octreotide outperforms ⁶⁸Ga-DOTA-TATE/-NOC PET in neuroendocrine tumor patients : results from a prospective, multicenter study
Source
The Journal of nuclear medicine - ISSN 0161-5505-64:4 (2023) p. 632-638